Evofem Biosciences, INC. (EVFM) SEC Filings — 2025
19 SEC filings for Evofem Biosciences, INC. (EVFM) in 2025.
Filings
- Evofem Biosciences, INC. 8-K Filing — 8-K · Nov 26, 2025
- Evofem Narrows Q3 Loss Amidst Sales Dip, Royalty Gain Boosts Bottom Line — 10-Q · Nov 13, 2025
- Evofem Eyes Nasdaq Re-listing, Reverse Split Amidst Product Growth Push — DEF 14A · Oct 29, 2025
- Evofem Biosciences Files 8-K: Agreement Termination & Shareholder Vote — 8-K · Oct 20, 2025
- Evofem Biosciences Enters Material Definitive Agreement — 8-K · Oct 17, 2025
- Evofem Biosciences Changes Special Meeting Date — DEFA14A · Sep 19, 2025
- Evofem Biosciences Merger Vote Approaching — DEFA14A · Sep 9, 2025
- Evofem Biosciences Files 8-K on Material Agreement — 8-K · Aug 26, 2025
- Evofem Narrows Losses Amidst Sales Dip, Going Concern Looms — 10-Q · Aug 14, 2025
- Evofem Biosciences Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 2, 2025
- Evofem Biosciences Enters Material Definitive Agreement — 8-K · May 22, 2025
- Evofem Biosciences Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Evofem Biosciences Files 8-K for Material Agreement — 8-K · May 8, 2025
- Evofem Biosciences Reports Material Agreement — 8-K · Apr 14, 2025
- Evofem Biosciences Reports Material Agreement — 8-K · Apr 3, 2025
- Evofem Biosciences Files 2024 Annual Report Amendment — 10-K/A · Mar 28, 2025
- Evofem Biosciences Enters Material Definitive Agreement — 8-K · Mar 26, 2025
- Evofem Biosciences Files 2024 10-K — 10-K · Mar 24, 2025
- Evofem Biosciences Faces Delisting Concerns — 8-K · Jan 10, 2025